首页> 美国卫生研究院文献>Springer Open Choice >Banking on iPSC- Is it Doable and is it Worthwhile
【2h】

Banking on iPSC- Is it Doable and is it Worthwhile

机译:在iPSC上银行业务-是否可行是否值得

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The discovery of induced pluripotent stem cells (iPSCs) and concurrent development of protocols for their cell-type specific differentiation have revolutionized studies of diseases and raised the possibility that personalized medicine may be achievable. Realizing the full potential of iPSC will require addressing the challenges inherent in obtaining appropriate cells for millions of individuals while meeting the regulatory requirements of delivering therapy and keeping costs affordable. Critical to making PSC based cell therapy widely accessible is determining which mode of cell collection, storage and distribution, will work. In this manuscript we suggest that moderate sized bank where a diverse set of lines carrying different combinations of commonly present HLA alleles are banked and differentiated cells are made available to matched recipients as need dictates may be a solution. We discuss the issues related to developing such a bank and how it could be constructed and propose a bank of selected HLA phenotypes from carefully screened healthy individuals as a solution to delivering personalized medicine.
机译:诱导多能干细胞(iPSC)的发现以及针对其细胞类型特异性分化的协议的同时开发已彻底改变了疾病的研究方法,并提高了可以实现个性化医学的可能性。要实现iPSC的全部潜能,需要解决为数以百万计的人获得合适的细胞所固有的挑战,同时满足提供治疗并保持可负担费用的监管要求。使基于PSC的细胞疗法广泛可及的关键是确定哪种细胞收集,存储和分配模式将起作用。在此手稿中,我们建议中度大小的库可能是一种解决方案,在该库中可以存储多种携带共同存在的HLA等位基因不同组合的品系,并向匹配的接收者提供分化的细胞。我们讨论了与建立这样的银行以及如何建立银行有关的问题,并提出了从经过精心筛选的健康个体中选择的HLA表型银行作为提供个性化药物的解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号